Sign in. It’s quick, free and it’s up to you.
An account is an optional way to support the work we do. Find out more.
Sign in. It’s quick, free and it’s up to you.
An account is an optional way to support the work we do. Find out more.
RESEARCH WORK carried out in collaboration by scientists at Trinity College in Dublin and at Cambridge, England has the potential to be used in new methods of treating asthma, atopic dermatitis and other allergic diseases.
The research published in Nature Immunology identified new processes which lead to the development of a novel cell which contribute to allergies. The report’s authors say that they discovered distinct and previously-unknown nuocytes (which contribute to the exacerbation of asthma) arising in bone marrow.
The work was performed by Prof Padraig Fallon, Science Foundation Ireland Stokes Professor of Translational Immunology at TCD, and Dr Andrew McKenzie of the Medical Research Council Laboratory for Molecular Biology in Cambridge.
The researchers say that their findings identify targets for allergic diseases which could be developed into treatments.
To embed this post, copy the code below on your site
have your say